VIVO
Weill Cornell Medical College
Index
Log in
Search form
Home
People
Organizations
Research
Support
Dissecting the role of CD4+ TFH-like cells as a therapeutic target and biomarker of immunotherapy activity
Grant
Overview
date/time interval
June 15, 2020 - January 1, 2022
awarded by
Parker Institute for Cancer Immunotherapy
administered by
Medicine-Hematology and Medical Oncology
sponsor award ID
SRA 203365-01
Affiliation
contributor
Zappasodi, Roberta
Principal Investigator
2020 - 2022